サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1418343

血糖測定器市場レポート：2030年までの動向、予測、競合分析

Glucometer Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

血糖測定器市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

血糖測定器の動向と予測

世界の血糖測定器市場は、2024年から2030年までのCAGRが8.9%で、2030年までに推定305億米ドルに達すると予測されます。この市場の主な促進要因は、世界の糖尿病有病率の増加、ヘルスケアインフラのコスト上昇、糖尿病管理に関する知識の増加です。世界の血糖測定器市場の将来は、施設販売、病院、診療所、小売販売、病院薬局、小売薬局、オンライン薬局の各市場における機会で有望視されています。

血糖測定器市場の洞察

Lucintelの予測では、自己血糖測定システムは使いやすく手頃な価格であるため、予測期間中最大のセグメントであり続ける。

この市場において、病院薬局はヘルスケア専門家にとっての利便性から最大セグメントであり続けると思われます。

北米は糖尿病の有病率が高いため、予測期間中も最大の地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界の血糖測定器市場は、2030年までに推定305億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の血糖測定器市場は、2024年から2030年にかけてCAGR 8.9%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、世界の糖尿病有病率の増加、ヘルスケアインフラのコスト上昇、糖尿病管理に関する知識の増加です。

Q4.市場の主要セグメントは？

A4.血糖測定器市場の将来性は、施設販売、病院、診療所、小売販売、病院薬局、小売薬局、オンライン薬局の各市場における機会により有望視されます。

Q5.市場の主要企業は？

A5.主な血糖測定器企業は以下の通りです。

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、自己血糖測定システムは使いやすく手頃な価格のため、予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は糖尿病有病率が高いため、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の血糖測定器市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の血糖測定器市場動向（2018-2023）と予測（2024-2030）
  • 製品別の世界の血糖測定器市場
    • 持続的血糖測定器
    • 自己血糖測定システム
  • 技術別の世界の血糖測定器市場
    • 侵襲的
    • 非侵襲的
  • タイプ別の世界の血糖測定器市場
    • ウェアラブル
    • 非ウェアラブル
  • 流通チャネル別の世界の血糖測定器市場
    • 施設販売
    • 病院
    • クリニック
    • 小売売上高
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の血糖測定器市場
  • 北米の血糖測定器市場
  • 欧州の血糖測定器市場
  • アジア太平洋の血糖測定器市場
  • その他地域の血糖測定器市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の血糖測定器市場の成長機会
    • 技術別の世界の血糖測定器市場の成長機会
    • タイプ別の世界の血糖測定器市場の成長機会
    • 流通チャネル別の世界の血糖測定器市場の成長機会
    • 地域別の世界の血糖測定器市場の成長機会
  • 世界の血糖測定器市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の血糖測定器市場の能力拡大
    • 世界の血糖測定器市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
目次

Glucometer Trends and Forecast

The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

A more than 150-page report is developed to help in your business decisions.

Glucometer by Segment

The study includes a forecast for the global glucometer by product, technique, type, distribution channel, and region.

Glucometer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous Glucose Monitoring Devices
  • Self-Monitoring Blood Glucose Systems

Glucometer Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Invasive
  • Non-Invasive

Glucometer Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wearable
  • Non-Wearable

Glucometer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Institutional Sales
  • Hospitals
  • Clinics
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Glucometer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Glucometer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glucometer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glucometer companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Glucometer Market Insights

Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.

North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Features of the Global Glucometer Market

Market Size Estimates: Glucometer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glucometer market size by various segments, such as by product, technique, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Glucometer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technique, type, distribution channel, and regions for the glucometer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glucometer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glucometer market size?

Answer: The global glucometer market is expected to reach an estimated $30.5 billion by 2030.

Q2. What is the growth forecast for glucometer market?

Answer: The global glucometer market is expected to grow with a CAGR of 8.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the glucometer market?

Answer: The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

Q4. What are the major segments for glucometer market?

Answer: The future of the glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key glucometer market companies?

Answer: Some of the key glucometer companies are as follows.

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which glucometer market segment will be the largest in future?

Answer: Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Q7. In glucometer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glucometer Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Glucometer Market by Product
    • 3.3.1: Continuous Glucose Monitoring Devices
    • 3.3.2: Self-Monitoring Blood Glucose Systems
  • 3.4: Global Glucometer Market by Technique
    • 3.4.1: Invasive
    • 3.4.2: Non-Invasive
  • 3.5: Global Glucometer Market by Type
    • 3.5.1: Wearable
    • 3.5.2: Non-Wearable
  • 3.6: Global Glucometer Market by Distribution Channel
    • 3.6.1: Institutional Sales
    • 3.6.2: Hospitals
    • 3.6.3: Clinics
    • 3.6.4: Retail Sales
    • 3.6.5: Hospital Pharmacies
    • 3.6.6: Retail Pharmacies
    • 3.6.7: Online Pharmacies
    • 3.6.8: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Glucometer Market by Region
  • 4.2: North American Glucometer Market
    • 4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
    • 4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.3: European Glucometer Market
    • 4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
    • 4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.4: APAC Glucometer Market
    • 4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
    • 4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.5: ROW Glucometer Market
    • 4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
    • 4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Glucometer Market by Product
    • 6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
    • 6.1.3: Growth Opportunities for the Global Glucometer Market by Type
    • 6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Glucometer Market by Region
  • 6.2: Emerging Trends in the Global Glucometer Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Glucometer Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega Corporation
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott